BDX vs NERV · P/E 34, rev $21.84B vs P/E 2.2, $12.4M cap
Becton Dickinson and Company (BDX) versus Minerva Neurosciences Inc (NERV) — a side-by-side from cached financials, not a winner call.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
Minerva Neurosciences Inc (NERV) is a biotechnology company listed on US.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
NERV does not have a complete income-statement cache yet.
BDX currently screens at market cap $50.30B and trailing P/E 33.9. NERV currently screens at market cap $12.4M and trailing P/E 2.2.
Not investment advice. Open the BDX and NERV stock pages for the full models.
Not investment advice.